CPG Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events

When:  Sep 16, 2021 from 11:30 to 12:30 (ET)
18CIG-logo-rgb.jpgOn Thursday, September 16, 2021 from 11:30 a.m.–12:30 p.m. ET, join leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar is designed so that attendees will know how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease.

Webinar Faculty:

  • Co-Moderator: Julie R. Brahmer, MD, MSc — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Expert Panel Chair)
  • Co-Moderator: Marc S. Ernstoff, MD — National Institute of Health (Expert Panel Chair)
  • David E. Gerber, MD — Harold C. Simmons Comprehensive Cancer Center (Expert Panel Member)
  • Jeffrey A. Sosman, MD — Northwestern University (Expert Panel Member)
  • Jarushka Naidoo, MBBCh, MHS — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Expert Panel Member)


REGISTER NOW


The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).
0c5fc50a2c9f4300afadbcc55b201f99.jpg
The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.

#ImmuneCheckpointInhibitors #AdverseEvents #ClinicalPracticeGuideline #Webinar #2021 #NoCEOffered
​​​